These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26936869)

  • 1. Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarction.
    Fellner B; Rohla M; Jarai R; Smetana P; Freynhofer MK; Egger F; Zorn G; Weiss TW; Huber K; Geppert A
    Eur Heart J Acute Cardiovasc Care; 2017 Jun; 6(4):348-358. PubMed ID: 26936869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Traeder F; Lele SS; Rajapurkar MM; Mukhopadhyay B; de Waha S; Desch S; Eitel I; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2017 Jan; 227():83-88. PubMed ID: 27865117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS;
    JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.
    Prondzinsky R; Unverzagt S; Lemm H; Wegener NA; Schlitt A; Heinroth KM; Dietz S; Buerke U; Kellner P; Loppnow H; Fiedler MG; Thiery J; Werdan K; Buerke M
    Clin Res Cardiol; 2012 May; 101(5):375-84. PubMed ID: 22212516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cardiogenic shock complicating acute myocardial infarction.
    Van Herck JL; Claeys MJ; De Paep R; Van Herck PL; Vrints CJ; Jorens PG
    Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):278-97. PubMed ID: 25624526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction.
    Goldberg RJ; Gore JM; Thompson CA; Gurwitz JH
    Am Heart J; 2001 Jan; 141(1):65-72. PubMed ID: 11136488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hospital mortality with intra-aortic balloon counterpulsation insertion before versus after primary percutaneous coronary intervention for cardiogenic shock complicating acute myocardial infarction.
    Abdel-Wahab M; Saad M; Kynast J; Geist V; Sherif MA; Richardt G; Toelg R
    Am J Cardiol; 2010 Apr; 105(7):967-71. PubMed ID: 20346314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiogenic shock complicating acute myocardial infarction; prognostic impact of early and late shock development.
    Lindholm MG; Køber L; Boesgaard S; Torp-Pedersen C; Aldershvile J;
    Eur Heart J; 2003 Feb; 24(3):258-65. PubMed ID: 12590903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in cardiogenic shock complicating acute myocardial infarction.
    Goldberg RJ; Samad NA; Yarzebski J; Gurwitz J; Bigelow C; Gore JM
    N Engl J Med; 1999 Apr; 340(15):1162-8. PubMed ID: 10202167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
    Hochman JS; Sleeper LA; Webb JG; Sanborn TA; White HD; Talley JD; Buller CE; Jacobs AK; Slater JN; Col J; McKinlay SM; LeJemtel TH
    N Engl J Med; 1999 Aug; 341(9):625-34. PubMed ID: 10460813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamics of interleukin 6 levels in the patients with cardiogenic and septic shock and in a control group of patients with uncomplicated AMI].
    Pařenica J; Maláska J; Jarkovský J; Helánová K; Jabandžiev P; Michálek J; Veselková Z; Littnerová S; Kubková L; Gál R; Sevčík P; Goldbergová MP; Litzman J; Čermáková Z; Špinar J
    Vnitr Lek; 2014 Feb; 60(2):114-22. PubMed ID: 24754415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of external mechanical recanalization in the treatment of cardiogenic shock in patients with myocardial infarction].
    Markov VA; Dem'ianov SV; Repin AN; Balakhonova MB; Krylov AL
    Kardiologiia; 2005; 45(1):4-8. PubMed ID: 15699931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction.
    Bangalore S; Gupta N; Guo Y; Lala A; Balsam L; Roswell RO; Reyentovich A; Hochman JS
    Am J Med; 2015 Jun; 128(6):601-8. PubMed ID: 25554376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; Denks D; de Waha S; Pöss J; Heine GH; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2015 Jul; 191():159-66. PubMed ID: 25965624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mortality prognostic factors of cardiogenic shock complicating an acute myocardial infarction and treated by percutaneous coronary intervention].
    Chodek A; Angioi M; Fajraoui M; Moulin F; Chouihed T; Maurer P; Méjean C; Carteaux JP; Popovic B; Piquemal R; Ethévenot G; Aliot E
    Ann Cardiol Angeiol (Paris); 2005 Mar; 54(2):74-9. PubMed ID: 15828461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
    Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
    Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.